SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000897069-23-001054
Filing Date
2023-08-02
Accepted
2023-08-02 17:09:45
Documents
1
Period of Report
2023-07-31

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 4068
  Complete submission text file 0000897069-23-001054.txt   5703
Mailing Address 228 PARK AVENUE S. #66643 NEW YORK NY 10003
Business Address 228 PARK AVENUE S. #66643 NEW YORK NY 10003 (516) 962-3186
Cambrian BioPharma Inc (Reporting) CIK: 0001797409 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39980 | Film No.: 231136882

Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Issuer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations